Study guide
15.2 Compounding Standards & Quality
APC Intern Written Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals
2 Legal Framework: PBS & Medicine Schedules
2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)
3 Legal Framework: Privacy, National Law & Pharmacy Board
3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards
4 Patient-Centred Medication Management
4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management
5 Primary Care & Judicious Use of Medicines
5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices
6 Dispensing & Clinical Appropriateness
6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes
7 Counselling & Acute Care
7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response
8 Therapeutics: Cardiovascular & Endocrine
8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders
9 Therapeutics: Infection, Respiratory & Gastrointestinal
9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health
10 Therapeutics: Neurology, Psychiatry & Pain
10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics
11 Therapeutics: Special Populations & Systems
11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment
12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology
12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management
13 Monitoring: Clinical Review
13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications
14 Monitoring: Safety & Adverse Drug Reactions
14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring
15 Compounding Medicines
15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations
16 Pharmaceutical Calculations
16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations
17 Promote Health & Well-Being
17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency
15.2 Compounding Standards & Quality
Key Takeaways Explain This Topic AI
Quality compounding depends on accurate weighing and measuring with calibrated equipment, controlled processes, and fit-for-purpose facilities—not approximate “eyeballing”.
Hygiene, PPE, and cleaning reduce microbial contamination and cross-contamination between products and patients.
Batch records and documentation create an auditable trail: formula source, quantities, calculations, operator, checks, BUD, and label text.
Labels for compounded medicines must identify the product as compounded and include critical details such as active strength, quantity, BUD, storage, and patient directions.
Error prevention includes independent calculation checks, clear units, segregation of hazardous materials, and professional responsibility when outsourcing to another compounder.
Last updated: August 2026
14.2 Compounding Standards & Quality
Quick Answer: Safe compounding is a quality system , not a casual mix. Use calibrated balances and measures , follow APF methods and professional standards, maintain hygiene and segregation , complete batch/compounding records , and issue labels that clearly show the product is compounded , with strength, BUD, storage, and directions . Prevent calculation and selection errors with checks . If you outsource , you still carry professional responsibility for suitability, communication, and patient counselling.
Standard 3.4 expects pharmacists to compound medicines to a standard that protects patients. Quality failures—wrong strength, contamination, missing BUD, illegible labels—cause real harm. The Intern Written Examination tests whether you can recognise those failure modes and the controls that prevent them.
- Accurate weighing, measuring, and equipment
- Weighing and measuring discipline
- Use a balance appropriate to the mass being weighed (sensitivity and capacity matched to the task)
- Zero/tare correctly; protect balances from drafts, vibration, and powder spills
- Prefer weighing solids over repeated volumetric guesses when accuracy matters
For liquids, use graduated measures appropriate to the volume; read menisci correctly; avoid household spoons for compounding stock
- Convert units carefully (mg ↔ g, % w/v, mg/mL)—unit errors are classic high-harm mistakes
- Calibration and maintenance
Equipment that is not calibrated or fit for purpose undermines every later step. Community pharmacies that compound should maintain procedures for checking balances, thermometers (if used), and measuring devices, and for removing defective equipment from service. For the exam, the principle is: do not rely on unvalidated kitchen scales or damaged glassware for patient-specific medicines.
Process control
Follow a written formula and method (APF standard formula or approved worksheet):
- Gather ingredients and confirm identity, grade, and expiry of starting materials
- Perform and record calculations before dispensing materials
- Weigh/measure with a witness or systematic self-check for high-risk items
Mix in the correct order (for example geometric dilution of potent powders; levigating agents before incorporating into bases)
Inspect the finished product (uniformity, absence of grit, correct appearance)
Package in suitable containers (light-resistant, child-resistant where required, appropriate for topical vs oral)
- Hygiene and contamination control
- Personal and environmental hygiene
- Clean work surfaces before and after compounding
Hand hygiene and appropriate PPE (gloves, gown/coat, hair cover as risk requires; eye protection for irritants)
- Minimise unnecessary conversation and traffic over open products
- Dedicate utensils where possible; wash and dry thoroughly between products
- Avoiding cross-contamination
Cross-contamination is a major quality risk—especially with:
- Potent hormones
- Antibiotics (allergy risk residues)
- Cytotoxic or hazardous powders
- Strong dyes and odorous substances
- Penicillin-class powders in environments serving allergic patients
Controls: segregation of workspace and equipment, closed containers, careful powder handling, cleaning validation mindset (documented cleaning of shared equipment), and refusing to prepare incompatible sequences without decontamination. Never prepare a product for a patient with a known severe allergy on equipment still contaminated with that allergen.
Microbial contamination of aqueous multi-dose products is reduced by clean technique, suitable preservatives when appropriate and compatible, patient counselling on hygiene of measuring devices, and realistic BUDs.
Documentation and batch records
If it is not documented, it is difficult to defend, repeat, or investigate. A compounding/batch record typically includes:
- Record element Why it matters
- Patient and prescriber identifiers Links product to clinical authority
- Date of preparation Starts the BUD clock and audit trail
- Formula reference (e.g. APF monograph / worksheet ID) Shows method source
- Ingredient names, batch/lot, expiry, quantities Traceability if a recall or ADR occurs
- Calculations Supports independent check
- Operator and checker identity Accountability
- Yield / quantity prepared Detects major process loss or error
- BUD and storage assigned Critical safety information
- Label text / version Ensures label matches record
- Deviations and problems Continuous quality improvement
Documentation is part of professional responsibility , not optional paperwork. On exam scenarios, choose options that include recording formula source, quantities, and checks—not “compound from memory and hand over”.
Labelling compounded products
Compounded medicines must be labelled so the patient, carer, and any other health professional can use them safely. Align with APF/professional labelling guidance and Poisons legislation requirements for the schedule of the medicine.
- Essential label content (practical checklist)
- Patient name
- Active ingredient(s) and strength (clear units; final concentration after compounding)
- Dose form and quantity supplied
- Directions for use (and measuring device advice for liquids)
- Beyond-use date and storage conditions
- Pharmacy name/address and telephone
- Date of supply / preparation
- Prescription/reference number as required
- Explicit identification that the product is compounded (so it is not mistaken for a manufacturer’s pack)
- Relevant cautionary advisory labels (for example external use only, shake the bottle, refrigerate)
Exam emphasis: missing BUD, missing strength, or failure to mark a product as compounded are common “unsafe label” patterns. Strength must reflect the finished product (e.g. mg/mL of suspension), not only the input powder weight without vehicle.
Distinguishing from proprietary packs
Patients may assume a pharmacy-packed product has the same shelf-life as a factory blister. Counselling and label wording must correct that assumption. Keep original manufacturer packs for proprietary products; for compounds, use containers suited to the preparation and label them completely.
Error prevention
High-yield error types in compounding:
- Calculation errors (decimal place, % vs mg/mL, adult vs paediatric dose concentration)
- Ingredient selection errors (wrong salt, wrong base, look-alike stock bottles)
- Unit and device errors (mg measured as g; syringe vs cup confusion at home)
- Process errors (skipped geometric dilution → hot spots of potent drug)
- Labelling transcription errors (correct compound, wrong directions)
Defences:
- Written worksheets with blank fields that force entry of each quantity
- Independent double-check of calculations for high-risk preparations
- Read-aloud verification of stock bottle names and strengths
- Standardised units on labels
- Segregated storage of finished compounds awaiting checking
Final clinical check: does the strength and directions match the prescription and patient age/weight?
Professional responsibility when outsourcing compounding
Not every pharmacy compounds every product. Outsourcing to a specialist compounding pharmacy or hospital service can improve quality for complex items—but outsourcing does not remove all responsibility.
- Responsibilities that remain with the supplying pharmacist
- Confirm the prescription is clinically appropriate and legally valid
- Confirm compounding is necessary (no suitable proprietary product)
- Communicate complete, accurate prescription details and patient factors (allergies, age, indication)
- Ensure the patient receives counselling on use, storage, BUD, and what to do if the product looks abnormal
- Manage continuity if supply is delayed
- Report and act on quality complaints or suspected adverse events
Choose outsource partners with appropriate licences, quality systems, and transparent certificates of analysis/batch documentation where relevant. Do not “sign off” a product you know is unsuitable simply because another facility made it.
Linking quality to APF and Board expectations
The APF supports method selection, general precautions, and labelling/BUD thinking. Pharmacy Board codes and guidelines, together with state/territory legislation, frame professional obligations for premises, supervision, and safe practice. For interns:
- Work within competence and supervised scope
- Escalate when facilities or training are inadequate
- Treat every compound as a patient-specific medicine requiring the same clinical filters as dispensing
- Putting it together for the exam
When a vignette describes a compounding near-miss, prioritise measurement accuracy , documentation , label completeness (strength, BUD, storage, compounded identity) , contamination control , and checks . Quality is how Standard 3.4 is operationalised after the decision to compound has been justified.